Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide for Cardiovascular Health in Obese Breast Cancer Survivors
NCT07769047Phase 4Not yet recruiting
- Sponsor
- Mayo Clinic
- Start
- Sep 2026
- Primary completion
- Jul 2031
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in obesity, sponsored by Mayo Clinic. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07769047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07769047.